ResearcherRegional Centre for BiotechnologyActive in the last 2 years

Samriddhi Arora

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-6820-9280; OpenAlex author ID A5020537613. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

The Ca2+ channel Orai3 drives gemcitabine resistance in pancreatic cancer through NFATc1-dependent SLIT3 expression. Co-author DOI 10.1016/j.jbc.2026.113480 ↗
Orai3 Regulates Pancreatic Cancer Metastasis by Encoding a Functional Store Operated Calcium Entry Channel. Co-author DOI 10.3390/cancers13235937 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Rajender K. Motiani · 2 shared papers, 2021–2026 · strength 0.60
- Paper The Ca2+ channel Orai3 drives gemcitabine resistance in pancreatic cancer through NFATc1-dependent SLIT3 expression. DOI 10.1016/j.jbc.2026.113480 ↗
- Paper Orai3 Regulates Pancreatic Cancer Metastasis by Encoding a Functional Store Operated Calcium Entry Channel. DOI 10.3390/cancers13235937 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.